Cas:959245-07-9 methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate manufacturer & supplier

Chemical Name:methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate

CAS.NO:959245-07-9

Synonyms:6-Cyano-4-azaindole-3-carboxylic acid methyl ester;1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid, 6-cyano-, methyl ester;Methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate

Molecular Formula:C₁₀H₇N₃O₂

Molecular Weight:201.182

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:431.3±40.0 °C at 760 mmHg

Density:1.4±0.1 g/cm3

Index of Refraction:1.645

PSA:78.77000

Exact Mass:201.053833

LogP:0.70

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-Cyano-4-azaindole-3-carboxylic acid methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate Use and application,Methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate technical grade,usp/ep/jp grade.

Related News: Singapore, Australia, New Zealand, and the United States have banned all foreign nationals traveling from China from entering the country. methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate manufacturer He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate supplier He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate vendor Health officials said it remained unclear where he had developed the disease. methyl 6-cyano-1H-pyrrolo[3,2-b]pyridine-3-carboxylate factory He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients.